Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms in relation to human disease, diagnosis and therapy. Research in disease model organisms is particularly welcome.
- Ulrich Mahlknecht, St Lukas Clinic, Solingen
- Marianne Rots, University Medical Center Groningen
Ulrich Mahlknecht is currently a Professor of medicine at the University of Heidelberg, and Head of the Department of Hematology/Oncology at St. Lukas Clinic in Solingen, Germany.
His research focuses on novel targeted immunological and epigenetic concepts in the treatment of solid tumors and hematological malignancies.
- 19 October 2014
- Why depression and aging are linked to increased disease risk
- 10 October 2014
- All the cell's a stage: One protein directs epigenetic players
The "Clinical Epigenetics Society" (CLEPSO) is a non-profit organization founded at Saarland University.
The society has five main objectives:
- Promotion and support of scientific research projects and initiatives within the field of clinical epigenetics.
- Promotion of the scientific exchange amongst its members.
- Encouragement and support of relations to national and international societies within the area of clinical and translational research.
- Development of an international research and scientific network within the field of clinical epigenetics.
- Providing a forum for encouraging discussions and contributions to the advancement of clinical epigenetics, through the Clinical Epigenetics journal, Blogs, scientific symposia, meetings, and newsletters.
From the blog
- 16 October 2014
- The epigenetic basis of immune function
In October 2011, Clinical Epigenetics became a fully open access journal and is now published as part of BioMed Central's portfolio of journals. To view the journal's content prior to this transition, please see SpringerLink.